Environmental Groups Call for Tighter Regulation of ‘Extreme Genetic Engineering’
By Brian Vastag,
Washington Post
| 03. 13. 2012
Genetically engineered microbes that might one day churn out biofuels, clean up toxic waste or generate new medicines need to be proved safe before they are released into the environment, a coalition of 111 environmental and social justice groups said Tuesday.
Led by the environmental advocacy group Friends of the Earth, the coalition also called for stronger government regulations over “extreme genetic engineering” and a moratorium on the commercial use and release of lab-created organisms.
“Without proper safeguards, we risk letting synthetic organisms and their products out of the laboratory with unknown potential to disrupt ecosystems, threaten human health and undermine social, economic and cultural rights,” the coalition said in a new report.
The technology to manipulate the genes of bacteria, yeast and other organisms has existed since the 1970s, leading to pest-resistant crops, bacteria that produce human insulin and other breakthroughs.
But in 2010, biologist J. Craig Venter announced that his institute had invented “synthetic biology” by transplanting the entire genome of one bacterium into a different species, which then reproduced. While not qualifying as an entirely...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...